University of Glasgow
Alteration of the Small Cell Lung Cancer Phenotype and Its Effect on Chemosensitivity
Abstract
dc:description.abstractSmall cell lung cancer (SCLC) accounts for approximately 25% of all lung cancers. It is distinguished from other lung cancers by the presence of neurosecretory granules, frequent peptide secretion, high levels of L-DOPA decarboxylase (DDC), creatine kinase BB isoenzyme (CKBB) ,neurone specific enolase (NSE) and bombesin-like immunoreactivity (BLI). It is a particularly aggressive neoplasm which has the potential for early metastatic dissemination, and by the time of diagnosis metastatic spread is often extensive. Consequently, surgical removal of the tumour is in most cases unlikely to result in a cure from the disease and chemotherapy is the most important treatment modality for SCLC. The eventual goal in the treatment of SCLC is to develop effective systemic therapy that will produce high response rates and a high percentage of long term disease-free survivors (cures).
Degree
thesis:*- Level dc:type.qualificationlevel
- PhD
- Grantor dc:publisher.institution
- University of Glasgow
- Year dc:date.issued
- 1989
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Murray, Alison M. B
Rights
- Language dc:language
- en